SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!
活力听兰
Lv1
10 积分
2024-03-13 加入
最近求助
最近应助
互助留言
Seven-year outcomes of venetoclax-ibrutinib therapy in mantle cell lymphoma: durable responses and treatment-free remissions
9小时前
求助中
Seven-year outcomes of venetoclax-ibrutinib therapy in mantle cell lymphoma: durable responses and treatment-free remissions
14小时前
已关闭
Combating relapsed and refractory Mantle cell lymphoma with novel therapeutic armamentarium: Recent advances and clinical prospects
3天前
已完结
Evaluation of Bruton tyrosine kinase inhibitors monotherapy and combination therapy in lymphocytic leukemia
4天前
已完结
Superiority of ibrutinib plus bendamustine and rituximab in newly diagnosed patients with mantle-cell lymphoma ineligible for intensive therapy: A network meta-analysis
5天前
已完结
Atrial Fibrillation Incidence Associated With Exposure to Anticancer Drugs Used as Monotherapy in Clinical Trials
5天前
已完结
Real-life diagnostic and therapeutic approach to CLL: a 2022 update from an expert panel in Tuscany
6天前
已完结
Waldenström Macroglobulinemia: Targeted Agents Taking Center Stage
6天前
已完结
Effect of CYP3A perpetrators on ibrutinib exposure in healthy participants
8天前
已完结
Itraconazole Increases Ibrutinib Exposure 10-Fold and Reduces Interindividual Variation-A Potentially Beneficial Drug-Drug Interaction
8天前
已完结
没有进行任何应助
没人上传【积分已退回】
9小时前
感谢,速度真快
4天前
感谢,速度真快
5天前
感谢,速度真快
5天前
感谢,速度真快
6天前
感谢,速度真快
6天前
感谢,速度真快
8天前
感谢,速度真快
8天前
感谢,速度真快
8天前
感谢,速度真快
9天前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论